1800-272-662
Shopping Cart 0
countryflagAU
Login

Sonic Healthcare Ltd

Healthcare AU SHL

21.2AUD
0.09(0.43%)

Last update at 2026-03-13T06:20:00Z

Day Range

20.9521.33
LowHigh

52 Week Range

20.1127.92
LowHigh

Fundamentals

  • Previous Close 21.11
  • Market Cap10477.84M
  • Volume1296897
  • P/E Ratio19.10
  • Dividend Yield5.12%
  • EBITDA1327.80M
  • Revenue TTM10421.97M
  • Revenue Per Share TTM21.39
  • Gross Profit TTM 3422.19M
  • Diluted EPS TTM1.11

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 750.87M 730.65M 931.19M 2077.20M 1828.59M
Minority interest -30.32500M -32.71000M -22.94700M -54.90000M 119.36M
Net income 513.60M 511.09M 684.98M 1460.57M 1315.04M
Selling general administrative 4695.28M 4375.05M 3868.38M 3678.97M 3423.17M
Selling and marketing expenses - 2861.28M 217.02M 206.13M 181.71M
Gross profit 3188.24M 2330.23M 6889.25M 7735.69M 7137.29M
Reconciled depreciation 815.37M 777.30M 702.93M 675.42M 641.59M
Ebit 936.19M 882.00M 1018.21M 2157.02M 1921.11M
Ebitda 1243.78M 1659.30M 1721.14M 2832.44M 2562.71M
Depreciation and amortization 307.58M 777.30M 702.93M 675.42M 641.59M
Non operating income net other - - - - -
Operating income 2920.67M 552.39M 1019.10M 2157.02M 1921.11M
Other operating expenses 6724.78M 8099.76M 3502.33M 4044.69M 3822.84M
Interest expense 180.51M 151.35M 87.03M 79.82M 92.52M
Tax provision 206.94M 186.85M 223.26M 561.74M 480.94M
Interest income 21.75M 24.76M 87.03M 79.82M 92.52M
Net interest income -158.76400M -126.58600M -87.02500M -79.81900M -92.51900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 206.94M 186.85M 223.26M 561.74M 480.94M
Total revenue 9645.45M 8934.20M 8168.95M 9340.15M 8754.12M
Total operating expenses 267.56M 249.79M 5871.04M 5578.67M 5216.18M
Cost of revenue 6457.21M 6603.97M 1279.69M 1604.46M 1616.83M
Total other income expense net -2169.80600M 178.26M 10.33M 17.92M -1.32900M
Discontinued operations - - - - -
Net income from continuing ops 543.92M 543.80M 707.93M 1515.47M 1347.66M
Net income applicable to common shares 513.60M 511.09M 684.98M 1460.57M 1315.04M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 16053.92M 14826.47M 13014.63M 12552.01M 11760.99M
Intangible assets 728.46M - 7789.62M 7361.49M 6712.25M
Earning assets - - - - -
Other current assets - 136.99M 113.80M 92.26M 71.64M
Total liab 7580.70M 6751.35M 5092.77M 5123.84M 5256.65M
Total stockholder equity 8323.50M 7917.62M 7736.50M 7273.14M 6384.99M
Deferred long term liab - - - - -
Other current liab 20.95M 393.18M 8.23M 21.37M 82.45M
Common stock - 4140.91M 3842.42M 3860.95M 4081.98M
Capital stock 4142.01M - 3842.42M 3860.95M 4081.98M
Retained earnings 3544.11M 3552.28M 3554.20M 3351.02M 2322.16M
Other liab - - 460.74M 368.69M 355.33M
Good will 9038.20M - 7237.43M 6852.96M 6231.85M
Other assets - - 80.19M 259.75M 103.13M
Cash 673.77M 645.00M 797.99M 780.00M 899.83M
Cash and equivalents - - - - -
Total current liabilities 2223.40M 2322.19M 1878.34M 2084.27M 2217.94M
Current deferred revenue - 27.49M 563.33M 702.50M 557.52M
Net debt 2815.45M 3870.37M 2302.49M 2232.74M 2334.98M
Short term debt - 661.03M 346.79M 341.86M 551.43M
Short long term debt 80.79M - - - 228.94M
Short long term debt total - 4515.37M 3100.48M 3012.74M 3234.81M
Other stockholder equity - 3.27M -7396.62000M -7217.87000M -6404.28400M
Property plant equipment - - 2798.11M 2624.86M 2552.92M
Total current assets 2605.63M 2352.99M 2133.17M 2305.91M 2284.57M
Long term investments 231.11M - 175.80M 145.22M 108.11M
Net tangible assets - - -53.11500M -88.34600M -327.26500M
Short term investments - - - - -
Net receivables 1336.53M 1362.17M 1022.17M 1217.46M 1088.72M
Long term debt 3408.43M - 1673.46M 1576.93M 1592.38M
Inventory 226.98M 208.83M 199.20M 216.19M 224.39M
Accounts payable 446.57M 1240.49M 959.99M 1018.55M 1026.54M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 221.16M 339.88M 61.17M -19.15800M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -0.14000M
Accumulated amortization - - - - -
Non currrent assets other 10.25M 8.81M 45.56M 45.54M 37.86M
Deferred long term asset charges - - - - -
Non current assets total 13448.29M 12473.48M 10881.46M 10246.10M 9476.42M
Capital lease obligations 1681.59M - 1427.02M 1435.80M 1413.49M
Long term debt total - - 2753.69M 2670.88M 2683.38M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -577.61800M -1805.44300M -580.04100M -81.20900M -20.92100M
Change to liabilities - - -75.54500M 17.29M 96.42M
Total cashflows from investing activities -577.61800M -1805.44300M -580.04100M -989.18000M -386.75000M
Net borrowings 242.92M 1347.09M -374.31300M -624.69200M -1582.05900M
Total cash from financing activities -735.92900M 592.41M -911.51100M -1349.29400M -1954.65800M
Change to operating activities - - 9.74M -41.81100M 56.65M
Net income 513.60M 511.09M 684.98M 1460.57M 1315.04M
Change in cash 28.77M -152.99300M 18.00M -119.83000M -330.32200M
Begin period cash flow 645.00M 797.99M 780.00M 899.83M 1230.15M
End period cash flow 673.77M 645.00M 797.99M 780.00M 899.83M
Total cash from operating activities 1296.79M 1071.51M 1471.03M 2225.82M 2042.84M
Issuance of capital stock -0.00800M 204.41M 84.27M 48.81M 53.63M
Depreciation 815.37M 777.30M 632.83M 675.42M 641.59M
Other cashflows from investing activities -146.80100M 51.42M -83.02800M -610.59100M 24.40M
Dividends paid -514.03300M -499.41300M -490.53000M 470.87M 426.23M
Change to inventory -4.50900M -0.01800M 27.46M 9.88M -65.53500M
Change to account receivables -66.93500M -207.83600M 244.26M -83.01700M -146.64400M
Sale purchase of stock -0.00800M -10.00000M -130.93300M -302.54800M 53.63M
Other cashflows from financing activities -52.56400M -449.68100M -255.09500M -206.65300M -205.45200M
Change to netincome - - 42.41M 2225.82M 34.02M
Capital expenditures 336.24M 579.50M 497.01M 378.59M 363.19M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -90.26600M -208.70400M 271.72M 1.99M 2.92M
Stock based compensation 22.54M 27.03M 18.45M 17.24M 12.64M
Other non cash items 35.56M -8.18300M 153.22M -2135.98300M -1956.63400M
Free cash flow 960.55M 492.01M 974.02M 1847.23M 1679.64M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SHL
Sonic Healthcare Ltd		 0.09 0.43% 21.20 19.10 15.48 1.01 1.22 1.52 8.99
IDX
Integral Diagnostics Ltd		 0.01 0.43% 2.32 57.75 15.80 1.12 1.30 1.89 12.08
HLS
Healius Ltd		 - -% 0.59 - 26.25 0.32 0.78 0.96 10.14
ACL
Australian Clinical Labs Ltd		 -0.02 0.97% 2.05 14.79 12.17 0.54 2.75 0.96 3.92
MVF
Monash Ivf Group Ltd		 -0.005 0.79% 0.63 15.88 12.64 0.92 0.97 1.63 7.05

Reports Covered

Stock Research & News

View All

Profile

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Sonic Healthcare Ltd

Grosvenor Place, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Dr. Colin Stephen Goldschmidt F.A.I.C.D., F.R.C.P.A., M.B.B.Ch. CEO, MD & Exec. Director 1954
Mr. Christopher David Wilks B.Com., F.A.C.I.D., F.A.I.C.D. Fin. Director, CFO & Exec. Director 1958
Mr. Peter Savage Chief Bus. Officer NA
Dr. Stephen Fairy Global Chief Medical Officer NA
Mr. David Byrne Chief Exec. Officer of The Doctors Laboratory 1959
Mr. Paul J. Alexander B.Ec., C.A., F.Fin Deputy CFO & Company Sec. 1966
Mrs. G. Schottdorf Chief Exec. Officer of Schottdorf Group NA
Dr. Julian Adler Chief Exec. Officer of Sonic Imaging NA
Prashan Kulasekera Assistant Company Sec. 1972
Mr. David Byrne Chief Executive Officer of The Doctors Laboratory 1959

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.